A Win For Atara Biotherapeutics, Inc.
Tue, Aug 09, 2022 at 07:16 PM
Atara Biotherapeutics, Inc. (ATRA:NASDAQ) jumped higher at $4.69, representing a gain of 29.2%. On Tue, Aug 09, 2022, ATRA:NASDAQ touched a New 2-Week High of $4.69. The stock got featured on our News Catalysts scanner on Mon, Aug 08, 2022 at 06:50 PM in the 'INVESTOR UPDATE' category. From Tue, Jul 26, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Wed, Jul 06, 2022 at $9.34 with a volume of 1M+.
About Atara Biotherapeutics, Inc. (ATRA:NASDAQ)
Atara Biotherapeutics Inc is engaged in the development of pharmaceutical products. Its focus lies on developing therapies addressing serious-life threatening diseases in the United States.
Top 10 Gainers:
- AeroClean Technologies Inc. (AERC:NASDAQ), 60.13%
- BBQ Holdings, Inc. (BBQ:NASDAQ), 46.59%
- Verona Pharma plc (VRNA:NASDAQ), 44.32%
- FaZe Holdings Inc. (FAZE:NASDAQ), 42.41%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 33.33%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 32.14%
- Akanda Corp. (AKAN:NASDAQ), 30.21%
- Atara Biotherapeutics, Inc. (ATRA:NASDAQ), 29.2%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 25.85%
- D-Wave Quantum Inc. (QBTS:NYSE), 24%